FA Imaging in Behçet Disease

Imaging is essential for diagnosis, disease staging, and prognostication.

Kanwaljeet Harjot Madan, MS(Ophth), FAICO

Retina Today

An 11-year-old girl presented with a sudden decrease in vision in her left eye for a week. She reported no history of trauma or positive family history. Her medical history included oral ulcers. On examination, her BCVA was 20/80 OD and hand motion at 20 cm OS. The anterior segment examination revealed the presence of 2+ cellular reaction in each eye. The fundus examination revealed the presence of vitreous hemorrhage in her left eye. Her right eye showed cystoid macular edema (CME) with active vasculitis. Fluorescein angiography in her right eye revealed the presence of hyper fluorescence of the disc, CME, and perivenular leakage in a fern-like pattern (Figure 1). Based on these findings and fundus and OCT imaging (Figures 2 and 3), she was diagnosed with Behçet disease. The patient was started on systemic corticosteroids, received an intravitreal anti-VEGF injection in each eye, and was scheduled to receive panretinal photocoagulation in each eye before being lost to follow-up.

Three Major Acquisitions Announced in Ophthalmology

Eyetube

Tarsus Pharmaceuticals enters into a definitive agreement to acquire Alkeus Pharmaceuticals; Harrow acquires dry eye disease nasal spray Tyrvaya from Viatris; and Italy-based Alfasigma enters into a share purchase agreement with Sever Life Sciences to acquire 100% of Nordic Pharma and its subsidiaries. Learn more about your ad choices. Visit megaphone.fm/adchoices

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Eyewire News: The Podcast

Get the latest information and breaking news in the ophthalmic field.

View Feed

Verify Then Trust: Using AI in Retina Coding

This framework can help ensure accuracy and consistency when integrating AI into retina coding and billing workflows.

Matthew Baugh, MHA, COT, OCS, OCSR

Retina Today

KEY TAKEAWAYS While AI tools offer meaningful efficiency gains, retina coding remains complex and dependent on precise clinical interpretation, payer policy, and documentation standards; thus, it is crucial to verify first, then trust. The quality of AI output depends on the quality of input. Vague or incomplete billing and coding questions often produce incomplete or even misleading answers. The author describes a practical four-step framework that can help ensure accurate and compliant coding decisions using AI. AI use is rapidly becoming common in retina practices, including to support documentation, coding, and claim review. While AI tools can offer meaningful efficiency gains, retina coding remains complex and dependent on precise clinical interpretation, payer policy, and documentation standards. When AI-generated output is used without verification, it can lead to inaccurate coding decisions. Thus, the safest approach is simple: Verify first, then trust. Retina procedures are complex, frequently bundled, and closely scrutinized by payers. Errors in Current Procedural Terminology (CPT) selection, modifier use, or diagnosis linkage can trigger denials, repayment, or audit exposure.

EyewireTV

08.19.2026

08.19.2026

Tamara R. Fountain, MD

Zubair Ansari, MD

Michelle Sun, MD, MPH

Gail Schmidt

Eyewire News

NICE Draft Guidance Recommends Against NHS Funding of Low-Dose Atropine for Childhood Myopia

Harrow Reports Lower Patient Discomfort with Iheezo Versus Proparacaine After Intravitreal Injections

FDA Expands TearCare's Indication to Include Improvement of Meibomian Gland Function

Stocks

Cataract

Genetically Predisposed to Capsular Bag Instability

Biocon Launches Eylea Biosimilar Yesafili

Elara 900: Reinventing the Clinical Workhorse

MIGS and Cataract Surgery

FDA Approves Outlook's Lytenava for Wet AMD

IJC Recap: Treating Inflammatory Dry Eye, an Emerging Option for Normal Tension Glaucoma, and the Role of Yag Laser Vitreolysis for Vitreous Floaters

08.21.2026

Harrow Reports Lower Patient Discomfort with Iheezo Versus Proparacaine After Intravitreal Injections

08.13.2026

Prevent Blindness Raises Concerns Over Proposed Head Start Vision Screening Changes

08.12.2026

Alfasigma Expands Presence in Europe with Acquisition of Nordic Pharma and the Lacrifill Canalicular Gel

08.11.2026

Omega Ophthalmics Closes $7 Million Financing, Schedules FDA Meeting for Gemini Refractive Capsule

Refractive

Netarsudil Joins the Glaucoma Toolbox

Exploring Nd:YAG Vitreolysis After Cataract Surgery for Symptomatic Eyes

Rethinking the Drop with iDose TR: Patient Conversations

FDA Approves Outlook's Lytenava for Wet AMD

IJC Recap: Treating Inflammatory Dry Eye, an Emerging Option for Normal Tension Glaucoma, and the Role of Yag Laser Vitreolysis for Vitreous Floaters

Evidence-Based Guidelines for KLEx: Translating a Global Expert Consensus Into Clinical Practice, Part 1

08.21.2026

Harrow Reports Lower Patient Discomfort with Iheezo Versus Proparacaine After Intravitreal Injections

08.13.2026

Prevent Blindness Raises Concerns Over Proposed Head Start Vision Screening Changes

08.12.2026

Alfasigma Expands Presence in Europe with Acquisition of Nordic Pharma and the Lacrifill Canalicular Gel

08.10.2026

WaveFront Dynamics Expands Scleral Lens Options Through Bausch + Lomb, WAVE Eye Care Integrations

Stay Updated

Follow Eyewire News

Retina

FA Imaging in Behçet Disease

Secondary IOL Surgery Is Unprofitable Under Current Medicare Reimbursement Rates. Now What?

Unity VCS - TetraSpot

Unity VCS - Core Technologies, Intelligent Fluidics

Genetic Testing in the Retina Practice

Bilateral Subretinal Fluid in a 66-Year-Old Woman

08.19.2026

Eyconis Initiates First-in-Human Clinical Trial of EYC-0305 in Treatment-Naïve Wet AMD

08.17.2026

Duravyu Misses Primary Endpoint in Phase 3 LUGANO Trial but Reduces Treatment Burden in Wet AMD

08.14.2026

Large UK Study Examines Impact of Anti-VEGF Treatment for DME on Progression to Proliferative Diabetic Retinopathy

08.13.2026

First Patient Receives Investigational Regenerative Cell Therapy for Non-Syndromic Retinitis Pigmentosa

Glaucoma

Three Major Acquisitions Announced in Ophthalmology

Customizing Care and Minimizing Risk With MIGS

Novel Approaches to Minimally Invasive Bleb Surgery

A Wider Frame of Reference

Choosing Between Bleb- and Trabecular Meshwork–Based MIGS

How to Thrive as a New Fellow

08.21.2026

Harrow Reports Lower Patient Discomfort with Iheezo Versus Proparacaine After Intravitreal Injections

08.18.2026

Balance Ophthalmics Announces Medicare Pricing for FSYX Ocular Pressure Adjusting Pump

08.13.2026

Prevent Blindness Raises Concerns Over Proposed Head Start Vision Screening Changes

08.12.2026

Alfasigma Expands Presence in Europe with Acquisition of Nordic Pharma and the Lacrifill Canalicular Gel

Featured Podcasts

Ophthalmology off the Grid

New Retina Radio

Eyewire News: The Podcast

Optometry

Establishing a Practical Collaborative Care Protocol